In support of improving patient care, this activity has been planned and implemented by
Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited with …

Cutaneous mucormycosis is the third most common clinical type of mucormycosis. The signs
and symptoms vary widely, and it is important to make the diagnosis as early as possible in …

The second wave of COVID-19 caused severe infections with high mortality. An increase in
the cases of COVID-19 associated mucormycosis (CAM) was reported predominantly in …

Background Fungal disease is frequent in India, but its incidence and prevalence are
unclear. This review aims at defining the frequency or burden of various fungal infections in …

The COVID-19 pandemic has undoubtedly highlighted the detrimental effect of secondary
pathogens in patients with a primary viral insult. In addition to superinfections with bacterial …

Background The aetiology of the major outbreak of COVID‐19‐associated mucormycosis
(CAM) in India in spring 2021 remains incompletely understood. Herein, we provide a …

COVID-19-associated mucormycosis (CAM) emerged as an epidemic in certain parts of the
world amidst the global COVID-19 pandemic. While rhino–orbital mucormycosis was well …

Mucormycosis is an invasive fungal infection caused by fungi belonging to order Mucorales.
Recently, with the increase in COVID-19 infections, mucormycosis infections have become a …

Abstract Coronavirus disease-19 (COVID-19) is an emerging infectious disease caused by
SARS-CoV-2 that has rapidly evolved into a pandemic to cause over 600 million infections …

Background As face masks became mandatory in most countries during the COVID-19
pandemic, adverse effects require substantiated investigation. Methods A systematic review …